Detalles de la búsqueda
1.
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
Br J Cancer
; 130(3): 457-466, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123705
2.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142371
3.
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials.
Br J Cancer
; 128(11): 2036-2043, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966233
4.
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Br J Cancer
; 129(4): 706-720, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37420000
5.
Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial.
Ann Surg
; 277(2): e320-e331, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520429
6.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
7.
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
Clin Trials
; 20(6): 594-602, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337728
8.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
9.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
10.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet
; 397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
11.
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
Br J Surg
; 109(3): 291-297, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179206
12.
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
Curr Oncol Rep
; 23(3): 29, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582975
13.
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial.
Dis Esophagus
; 33(8)2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591823
14.
Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Br J Cancer
; 120(2): 256-268, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30482913
15.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
16.
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial.
Histopathology
; 72(7): 1180-1188, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29465751
17.
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.
Lancet Oncol
; 18(9): 1249-1260, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28784312
18.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Lancet Oncol
; 18(3): 357-370, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28163000
19.
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Lancet
; 388(10055): 2004-2014, 2016 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27604504
20.
Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
Br J Surg
; 109(9): e106, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35554502